08/04/2025
7:00 AM | Verve Therapeutics (Filer)
| Form 15-12G | |
07/28/2025
11:15 PM | Verve Therapeutics (Filer)
| Form EFFECT | |
07/28/2025
4:15 PM | Cumbo Alexander (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Mikhail Sheila (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Tatsis Ourania (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Politi Jason (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Morrison Jodie Pope (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | COATS LONNEL (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | ADELMAN BURT A (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Lister Troy (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VERV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Verve Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/28/2025
4:15 PM | Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | Verve Therapeutics (Issuer)
Yeshwant Krishna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:15 PM | MacLean Michael F (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:19 PM | Alphabet Inc. (Reporting)
Alphabet Inc. (Reporting)
GV 2017 GP, L.L.C. (Reporting)
GV 2017 GP, L.P. (Reporting)
GV 2017, L.P. (Reporting)
GV 2019 GP, L.L.C. (Reporting)
GV 2019 GP, L.P. (Reporting)
GV 2019, L.P. (Reporting)
GV 2023 GP, L.L.C. (Reporting)
GV 2023 GP, L.P. (Reporting)
GV 2023, L.P. (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2025
4:21 PM | GV 2017, L.P. (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
07/25/2025
4:12 PM | Verve Therapeutics (Filer)
| Form POS AM | |
07/25/2025
10:30 AM | Verve Therapeutics (Filer)
| Form S-8 POS | |
07/25/2025
10:32 AM | Verve Therapeutics (Filer)
| Form S-8 POS | |
07/25/2025
10:33 AM | Verve Therapeutics (Filer)
| Form S-8 POS | |
07/25/2025
10:38 AM | Verve Therapeutics (Filer)
| Form S-8 POS | |
07/25/2025
10:39 AM | Verve Therapeutics (Filer)
| Form S-8 POS | |
07/25/2025
10:46 AM | Verve Therapeutics (Filer)
| Form POSASR | |
07/25/2025
7:30 AM | Nasdaq Stock Market LLC (Filed by)
Verve Therapeutics (Subject)
| Form 25-NSE | |
07/22/2025
4:16 PM | ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
| Form SC TO-T/A | |
07/22/2025
4:17 PM | Verve Therapeutics (Subject)
| Form SC 14D9/A | |
07/15/2025
5:14 AM | Verve Therapeutics (Subject)
| Form SC 14D9/A | |
07/15/2025
5:16 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2025
5:04 AM | ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
| Form SC TO-T/A | |
06/25/2025
6:00 AM | Verve Therapeutics (Subject)
| Form SC 14D9 | |
06/25/2025
5:10 AM | ELI LILLY & Co (Filed by)
Verve Therapeutics (Subject)
| Form SC TO-T | |
06/17/2025
6:18 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
3:17 PM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
11:15 PM | Verve Therapeutics (Filer)
| Form EFFECT | |
05/14/2025
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2025
6:45 AM | Verve Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
6:48 AM | Verve Therapeutics (Filer)
| Form ARS | |
04/25/2025
6:30 AM | Verve Therapeutics (Filer)
| Form DEF 14A | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
04/17/2025
4:40 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:57 AM | Verve Therapeutics (Filer)
| Form POS AM | |
02/27/2025
7:16 AM | Verve Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:45 AM | Verve Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:24 AM | Verve Therapeutics (Filer)
| Form POSASR | |
02/27/2025
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:53 AM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/10/2025
8:24 PM | ARK Investment Management LLC (Filed by)
Verve Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
8:00 AM | Ashe Andrew D. (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Nickerson Joan (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Kathiresan Sekar (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Lister Troy (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Politi Jason (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
8:00 AM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
3:30 PM | Dorval Allison (Reporting)
Verve Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
11/08/2024
1:17 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
11/05/2024
6:15 AM | Verve Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:30 AM | Verve Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
12:52 PM | VANGUARD GROUP INC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
10/16/2024
12:06 PM | STATE STREET CORP (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G | |
09/09/2024
3:36 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Verve Therapeutics (Subject)
| Form SC 13G/A | |
